Performant Healthcare, Inc.
Performant Healthcare, Inc. (PHLT) Financial Performance & Income Statement Overview
Explore the financials of Performant Healthcare, Inc. (PHLT), including yearly and quarterly data on income, cash flow, and balance sheets.
Performant Healthcare, Inc. (PHLT) Income Statement & Financial Overview
Review Performant Healthcare, Inc. PHLT income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $33.27M | $34.77M | $31.52M | $29.36M |
| Cost of Revenue | $33.12M | $35.45M | $33.67M | $0.00 |
| Gross Profit | $149999.00 | -$689000.00 | -$2.15M | $29.36M |
| Gross Profit Ratio | $0.005 | -$0.02 | -$0.07 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $25.36M | $26.71M | $25.97M | $24.53M |
| Operating Expenses | $33.12M | $35.45M | $33.67M | $32.10M |
| Total Costs & Expenses | $33.12M | $35.45M | $33.67M | $32.10M |
| Interest Income | $98000.00 | $99000.00 | $93000.00 | $61000.00 |
| Interest Expense | $289000.00 | $306000.00 | $313000.00 | $300000.00 |
| Depreciation & Amortization | $1.60M | $1.38M | $2.02M | $2.04M |
| EBITDA | $1.85M | $785000.00 | -$41000.00 | -$645000.00 |
| EBITDA Ratio | $0.06 | $0.02 | -$0.001 | -$0.02 |
| Operating Income | $150000.00 | -$689000.00 | -$2.15M | -$2.74M |
| Operating Income Ratio | $0.005 | -$0.02 | -$0.07 | -$0.09 |
| Other Income/Expenses (Net) | -$191000.00 | -$207000.00 | -$220000.00 | -$239000.00 |
| Income Before Tax | -$41000.00 | -$896000.00 | -$2.37M | -$2.98M |
| Income Before Tax Ratio | -$0.001 | -$0.03 | -$0.08 | -$0.10 |
| Income Tax Expense | $40000.00 | -$398000.00 | $15000.00 | $16000.00 |
| Net Income | -$81000.00 | -$498000.00 | -$2.38M | -$3.00M |
| Net Income Ratio | -$0.002 | -$0.01 | -$0.08 | -$0.10 |
| EPS | -$0.001 | -$0.006 | -$0.03 | -$0.04 |
| Diluted EPS | -$0.001 | -$0.006 | -$0.03 | -$0.04 |
| Weighted Avg Shares Outstanding | $78.31M | $77.75M | $77.75M | $76.97M |
| Weighted Avg Shares Outstanding (Diluted) | $78.31M | $77.75M | $77.75M | $76.97M |
The company's financials show resilient growth, with revenue advancing from $29.36M in Q2 2024 to $33.27M in Q1 2025. Gross profit remained healthy with margins at 1% in Q1 2025 compared to 100% in Q2 2024. Operating income hit $150000.00 last quarter, sustaining a consistent 1% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.85M. Net income rose to -$81000.00, while earnings per share reached -$0.001. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan